Regulation of REG4 Expression and Prediction of 5-Fluorouracil Sensitivity by CDX2 in Ovarian Mucinous Carcinoma

Conclusion: CDX2 promotes resistance to paclitaxel and sensitivity to 5-FU. Novel 5-FU-based chemotherapy based on CDX2 may be used in ovarian mucinous carcinoma.

Source: Cancer Genomics and Proteomics - October 27, 2019 Category: Cancer & Oncology Authors: KOH, I., NOSAKA, S., SEKINE, M., SUGIMOTO, J., HIRATA, E., KUDO, Y. Tags: Article Source Type: research